41.08
-1.71
(-4.00%)
At close: January 10 at 9:17:06 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-3,207,000.00
-3,118,000.00
4,981,000.00
13,620,000.00
2,027,000.00
Investing Cash Flow
1,950,000.00
4,206,000.00
-5,176,000.00
-8,523,000.00
-1,672,000.00
Financing Cash Flow
-50,000.00
-1,377,000.00
-3,448,000.00
-873,000.00
2,033,000.00
End Cash Position
1,647,000.00
2,928,000.00
3,217,000.00
6,860,000.00
2,636,000.00
Income Tax Paid Supplemental Data
--
--
2,729,000.00
480,000.00
1,000.00
Interest Paid Supplemental Data
--
39,000.00
25,000.00
14,000.00
9,000.00
Capital Expenditure
-749,000.00
-707,000.00
-400,000.00
-284,000.00
-68,000.00
Issuance of Capital Stock
70,000.00
46,000.00
65,000.00
124,000.00
2,039,000.00
Repayment of Debt
--
--
--
-140,000.00
-6,215.00
Repurchase of Capital Stock
--
-1,153,000.00
-3,329,000.00
-857,000.00
--
Free Cash Flow
-3,956,000.00
-3,825,000.00
4,581,000.00
13,336,000.00
1,959,000.00
12/31/2020 - 12/12/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
22UA.F BioNTech SE
120.20
+1.52%
ABVX.PA ABIVAX Société Anonyme
6.47
+2.21%
9LB.F Legend Biotech Corporation
33.00
+5.10%
7IZ.MU Ziccum AB
0.0298
-29.72%
9LB.DU Legend Biotech Corp
31.00
-1.27%
5KW.F SkinBioTherapeutics plc
0.1720
+1.18%
HQ1.MU Oruka Therapeutics Inc. R
18.60
0.00%
IKAP.MU Aurinia Pharmaceuticals Inc
8.14
0.00%
HDP1.F Arrowhead Pharmaceuticals, Inc.
18.30
-3.69%
ORN.F Oryzon Genomics S.A.
1.5020
+2.18%